Compounded Hormone Therapy could be Restricted!
Updated: Aug 25, 2020
We're collecting cBHT (Compounded BioIdentical Hormone Therapy) patient testimonials (and we desperately need you!) With the NASEM (National Academy of Science, Engineering and Medicine) study on cBHT released, the FDA is considering restricting the use of compounded hormone therapy, something that would affect patients across the country. You can read the NASEM study at
NASEM ignored at least one critical piece of information: patient outcomes. We aim to correct that by collecting and aggregating clinical outcome data, as well as by collecting testimonials from the patients themselves.
Working with our grassroots organization, the Partnership for Personalized Prescriptions (P3), the Alliance for Pharmacy Compounding (APC) has created a Patient Testimonial Portal where cBHT patients (as well as prescribers and compounders) can share their cBHT experiences.
If you are taking or have taken compounded hormone therapy, please take a few minutes to share your experiences. If you have received patient testimonials, please share those, too (minus identifying information). And if you know other patients who have used cBHRT, share the link with them.
It's A4PC.org/cbhtandme. The site allows you to type in a short testimonial, or even upload a document or an audio or video recording.